Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Luke Nathaniel Walker Insider Profile
4 Followers
Luke Nathaniel Walker, SVP, Clinical Development at Cascadian Therapeutics, holds 72.48K shares in Zentalis Pharmaceuticals (Ticker: ZNTL), holds 0.00 shares in Harpoon Therapeutics (Ticker: HARP), holds 0.00 shares in Cascadian Therapeutics (Ticker: CASC).
Luke Nathaniel Walker Cascadian Therapeutics (CASC)SVP, Clinical Development
Cascadian Therapeutics (CASC)
SVP, Clinical Development
Not Ranked
Luke Nathaniel Walker has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Luke Nathaniel Walker holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Luke Nathaniel Walker
Luke Nathaniel Walker's Trading History
Cascadian Therapeutics
Mar 13, 2018
―
Uninformative Sell
―
$0.00
Harpoon Therapeutics
Mar 11, 2024
―
Uninformative Sell
―
$0.00
Zentalis Pharmaceuticals
May 29, 2024
Director
Uninformative Buy
―
$234.11K
Context Therapeutics
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Luke Nathaniel Walker's performance on stock
You May Also Like
Luke Nathaniel Walker insider profile FAQ
What is the percentage of profitable transactions made by Luke Nathaniel Walker?
The percentage of profitable transactions made by Luke Nathaniel Walker is ―.
What is the average return per transaction made by Luke Nathaniel Walker?
The average return per transaction made by Luke Nathaniel Walker is ―.
What stocks does Luke Nathaniel Walker hold?
Luke Nathaniel Walker holds: CASC, HARP, ZNTL, CNTX stocks.
What was Luke Nathaniel Walker’s latest transaction?
Luke Nathaniel Walker latest transaction was an Uninformative Buy of ―.
What was Luke Nathaniel Walker's most profitable transaction?
Luke Nathaniel Walker’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Luke Nathaniel Walker's role in Cascadian Therapeutics?
Luke Nathaniel Walker's role in Cascadian Therapeutics is SVP, Clinical Development.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.